DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer


NCT00024375

Interventional

Phase 2

Unknown status
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DHA-paclitaxel in treating patients who have metastatic pancreatic cancer.
Jun 30,2001
All
18 Years
N/A

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.